Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
J Intern Med. 2022 Mar;291(3):317-326. doi: 10.1111/joim.13391. Epub 2021 Oct 19.
Obesity is associated with subclinical myocardial injury as quantified by concentrations of cardiac troponin T, but whether lifetime excess weight history is associated with increased concentrations of cardiac troponin I (cTnI) and how indices of abdominal adiposity and glycemic dysregulation affect these associations remain unclear.
We analyzed cTnI with a high-sensitivity assay in 9739 participants in the Trøndelag Health (HUNT) Study at study visit 4 (2017-2019). BMI was assessed at study Visit 1 (1984-1986), 2 (1995-1997), 3 (2006-2008), and 4.
Median age at visit 4 was 68.7 years and 59% were women. Concentrations of cTnI were detectable in 84.1% of study participants, with a median of 2.5 (1.5-4.5 ng/L). We identified three clusters of BMI trajectories from visit 1 to 4, (1) stable normal weight, (2) stable overweight, and (3) stable obesity. Participants in clusters 2 and 3 were at increased risk of elevated concentrations of cTnI at visit 4 (odds ratio 1.27, 95% CI 1.09-1.47, and odds ratio 1.70, 95% CI 1.33-2.17, p for trend <0.001). Participants in cluster 3 had 22.0 (95% CI 14.1-29.9) higher concentrations of cTnI compared to participants in cluster 1 (p for trend <0.001). Dysregulated glucose metabolism and abdominal obesity did not influence our results.
Individuals with stable overweight or obesity are at increased risk of subclinical myocardial injury, independently of glycemic dysregulation and abdominal adiposity. Our data support a direct detrimental effect of long-standing obesity on cardiovascular health.
肥胖与心脏肌钙蛋白 T 浓度量化的亚临床心肌损伤有关,但终生超重史是否与心脏肌钙蛋白 I(cTnI)浓度升高有关,以及腹部肥胖和血糖调节紊乱的指标如何影响这些关联尚不清楚。
我们在特隆赫姆健康(HUNT)研究的 9739 名参与者中分析了第 4 次(2017-2019 年)的高敏 cTnI。BMI 在第 1 次(1984-1986 年)、2 次(1995-1997 年)、3 次(2006-2008 年)和 4 次就诊时进行评估。
第 4 次就诊时的中位年龄为 68.7 岁,59%为女性。研究参与者中有 84.1%可检测到 cTnI 浓度,中位数为 2.5(1.5-4.5ng/L)。我们从第 1 次就诊到第 4 次就诊确定了三种 BMI 轨迹群,(1)稳定的正常体重,(2)稳定的超重,和(3)稳定的肥胖。处于群 2 和群 3 的参与者在第 4 次就诊时发生 cTnI 浓度升高的风险增加(优势比 1.27,95%置信区间 1.09-1.47,和优势比 1.70,95%置信区间 1.33-2.17,p 趋势<0.001)。与群 1 相比,群 3 的参与者的 cTnI 浓度高 22.0(95%置信区间 14.1-29.9)(p 趋势<0.001)。血糖调节紊乱和腹部肥胖并不能影响我们的结果。
稳定超重或肥胖的个体发生亚临床心肌损伤的风险增加,与血糖调节紊乱和腹部肥胖无关。我们的数据支持长期肥胖对心血管健康的直接不良影响。